AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2025
May 19, 2025
35599_dirs_2025-05-19_acf971a0-0c05-4522-a25e-6536622fdffb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2025-05-16
Reporting Person: Hackman Jeffrey S. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-16 | Common Shares | P | 1035 | $6.75 | Acquired | 1035 | Direct |
| 2025-05-19 | Common Shares | P | 13965 | $6.99 | Acquired | 15000 | Direct |
Footnotes
F1: Transaction Code P - Open market or private purchase of non-derivative or derivative security
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20